<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03092388</url>
  </required_header>
  <id_info>
    <org_study_id>HDZNRW-KA_004_TB</org_study_id>
    <nct_id>NCT03092388</nct_id>
  </id_info>
  <brief_title>Leg Fluid Shift in Patients With Chronic Heart Failure and Obstructive or Central Sleep Apnea</brief_title>
  <official_title>Evaluation Eines Leg Fluid Shift Und Erörterung Der hämodynamischen Und Respiratorischen Auswirkungen Auf Patienten Mit Chronischer Herzinsuffizienz Und Obstruktiver Oder Zentraler Schlafapnoe</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heart and Diabetes Center North-Rhine Westfalia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heart and Diabetes Center North-Rhine Westfalia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to investigate the influence of a potential leg fluid shift (LFS) in patients
      with chronic heart failure (CHF) and obstructive sleep apnea (OSA) or central sleep apnea
      (CSA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic heart failure (CHF) is a common disease in general western population with high
      levels of morbidity and mortality. Prospective risk factors need to be identified and
      investigated. The prevalence for sleep disordered breathing (SDB) in patients with CHF is
      higher compared to general population. Especially the occurence of CSA with its special
      breathing pattern of Cheyne-Stokes-Respiration (CSR) is frequent in CHF patients.The
      pathophysiology and relation inbetween sleep apnea (SA) and CHF isn´t completely identified
      yet. Multiple theories with different strategies try to explain the pathophysics and
      development of SA. Following one of these theories, patients with CHF often develop edema in
      lower body compartments. The idea is a possible influence of retrograde nocturnal LFS from
      lower body to upper body compartments which could induce pulmonal congestion. Therefore, an
      increased pulmonary capillary wedge pressure (PCWP) could irritate special pulmonal receptors
      resulting in CSR with periods of hyperventilation, related hypocapnia and central apnea
      events. OSA could be induced by fluid accumulation in the upper airway by retrograde fluid
      shift.

      Patients with known CHF receive fluid measurements by b multi frequency bioimpedance analysis
      (mfBIA) the evening before and the morning after sleep is recorded using polygraphy (PG) or
      polysomnography (PSG) in hospital. Sleep results are analyzed by physicians using current
      guidelines of the American Academy of Sleep Medicine (AASM).

      Capillary blood gas (CBG) samples are taken before and after sleep to examine the relation of
      fluid shift and blood gas changes.

      A subgroup of the study group undergo additional investigation. Hemodynamic effects (e.g.
      reduced cardiac output (CO)) as a cause of a potential fluid shift is measured during
      wakefulness by using a tilting table. Hemodynamically relevant parameters are recorded
      non-invasively.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>∆ Leg Fluid Shift (LFS)</measure>
    <time_frame>one night</time_frame>
    <description>[%] Difference between the raw data of leg fluid volume before and after sleep.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Apnea-Hypopnea-Index (AHI)</measure>
    <time_frame>one night</time_frame>
    <description>[/h], definition after current AASM guideline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cheyne-Stokes-Respiration</measure>
    <time_frame>one night</time_frame>
    <description>[min] + [(%) of Total Sleep Time (TST)]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen-Desaturation-Index (ODI)</measure>
    <time_frame>one night</time_frame>
    <description>[/h], definition after current AASM guideline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time Oxygen Saturation &lt; 90% (TSpO2&lt;90%)</measure>
    <time_frame>one night</time_frame>
    <description>[min] + [% (of TST)]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen Saturation (SpO2)</measure>
    <time_frame>one night</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Efficiency</measure>
    <time_frame>one night</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Longest Apnea time</measure>
    <time_frame>one night</time_frame>
    <description>[min]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Longest Hypopnea time</measure>
    <time_frame>one night</time_frame>
    <description>[min]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>∆ partial pressure in capillary blood of carbon dioxide (pcCO2)</measure>
    <time_frame>one night</time_frame>
    <description>[mmHG] Difference of pcCO2 before and after sleep</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>∆ partial pressure in capillary blood of oxygen (pcO2)</measure>
    <time_frame>one night</time_frame>
    <description>[mmHG] Difference of pcO2 before and after sleep</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>∆ Resistance</measure>
    <time_frame>one night</time_frame>
    <description>[Ohm]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>∆ Reactance</measure>
    <time_frame>one night</time_frame>
    <description>[Ohm]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>∆ Total Body Water (TBW)</measure>
    <time_frame>one night</time_frame>
    <description>[l]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure (systolic, diastolic, mean)</measure>
    <time_frame>one night</time_frame>
    <description>[mmHg]</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Cardiac Index</measure>
    <time_frame>one hour</time_frame>
    <description>[(l/min)/m²] Cardiac output from left ventricle related to body surface during tilting table</description>
  </other_outcome>
  <other_outcome>
    <measure>∆ pcCO2</measure>
    <time_frame>one hour</time_frame>
    <description>[mmHG] Difference of pcCO2 before and after tilting table</description>
  </other_outcome>
  <other_outcome>
    <measure>∆ pcO2</measure>
    <time_frame>one hour</time_frame>
    <description>[mmHG] Difference of pcO2 before and after sleep</description>
  </other_outcome>
  <other_outcome>
    <measure>Thoracic Fluid Content (TFC)</measure>
    <time_frame>one hour</time_frame>
    <description>[1/kOhm]</description>
  </other_outcome>
  <other_outcome>
    <measure>∆ Leg Fluid Shift</measure>
    <time_frame>one hour.</time_frame>
    <description>[%] Difference between the raw data of leg fluid volume before and after tilting table.</description>
  </other_outcome>
  <other_outcome>
    <measure>∆ Total Body Water</measure>
    <time_frame>one hour</time_frame>
    <description>[l]</description>
  </other_outcome>
  <other_outcome>
    <measure>Oxygen Saturation</measure>
    <time_frame>one hour</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Blood Pressure (systolic, diastolic and mean)</measure>
    <time_frame>one hour</time_frame>
    <description>[mmHg]</description>
  </other_outcome>
  <other_outcome>
    <measure>∆ Resistance (legs, body)</measure>
    <time_frame>one hour</time_frame>
    <description>[Ohm] electrical resistance</description>
  </other_outcome>
  <other_outcome>
    <measure>∆ Reactance (legs, body)</measure>
    <time_frame>one hour</time_frame>
    <description>[Ohm] capacitive resitance</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Obstructive Sleep Apnoea</condition>
  <condition>Central Sleep Apnoea</condition>
  <condition>Cheyne Stokes Respiration</condition>
  <arm_group>
    <arm_group_label>Study Group Basic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive Multi Frequency Bioimpedance Analysis (mfBIA) before and after sleep recording by Polysomnography/Polygraphy (PSG/PG) in hospital. Capillary Blood Gas Analysis (CBGA) is performed before and after sleep according to mfBIA.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study Group Extended</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive Multi Frequency Bioimpedance Analysis (mfBIA) before and after sleep recording by Polysomnography/Polygraphy (PSG/PG) in hospital. Capillary Blood Gas Analysis (CBGA) is performed before and after sleep according to mfBIA.
Additionally, during daytime a special test with random parts of the study group basic is performed:
A tilting table with hemodynamic monitoring is used to induce an artificial LFS by moving patients from vertical into horizontal position. Bodyfluid changes are monitored by mfBIA during this procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Multi Frequency Bioimpedance Analysis (mfBIA)</intervention_name>
    <description>Multi Frequency Bioimpedance Analysis (mfBIA) uses very small electric current at different frequencies (5, 50, 100 kHz) to measure the resistance and reactance of the entire body and different segmental body compartiments. With a special software total body fluid can be calculated. By analyzing raw data at different frequencies a detailed view on body and segments fluid distribution is possible.</description>
    <arm_group_label>Study Group Basic</arm_group_label>
    <arm_group_label>Study Group Extended</arm_group_label>
    <other_name>Nutriguard M, Data Input, Darmstadt, Germany</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Polysomnography/Polygraphy (PSG/PG)</intervention_name>
    <description>Sleep is digital recorded by using PSG/PG in hospital and manually analyzed by physicians according to current AASM guidelines.</description>
    <arm_group_label>Study Group Basic</arm_group_label>
    <arm_group_label>Study Group Extended</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Capillary Blood Gas Analysis (CBGA)</intervention_name>
    <description>CBGA is a less invasive method to gain arterial blood like gas samples without the punctation of an artery. After inducing a good capillary perfusion, capillary blood is taken by a small punctation of the tip of one ear. The sample is automatically analysed in a blood gas analyzer.</description>
    <arm_group_label>Study Group Basic</arm_group_label>
    <arm_group_label>Study Group Extended</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Tilting Table with Hemodynamic Monitoring</intervention_name>
    <description>A tilting table offers the opportunity to turn a study subject automatically from vertical into horizontal position and back. By using non-invasive monitoring technique, hemodynamic parameters are recorded permanently.</description>
    <arm_group_label>Study Group Extended</arm_group_label>
    <other_name>Task Force Monitor, CNsystems, Vienna, Austria</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic Heart Failure

          -  reduced left ventricular ejection fraction (LVEF) ≤ 45%

          -  NYHA I - IV

        Exclusion Criteria:

          -  current existing sleep apnoea breathing therapy

          -  significant chronic obstructive pulmonary disease (COPD) Tiffenau-Index: &lt;70%

          -  respiratory insufficiency with need for a long time oxygen therapy

          -  hypercapnic state in rest at day time

          -  acute myocardial infarction at moment of study

          -  instable angina pectoris at moment of study

          -  cardiac surgery in last twelve weeks

          -  stroke or TIA in last twelve weeks

          -  implantable cardioverter-defibrillator, if there is no security clearance of the
             fabricator

          -  chronic kidney disease &gt; Stage III
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Bitter, MD</last_name>
    <role>Study Director</role>
    <affiliation>Herz- und Diabeteszentrum NRW, Ruhr-Universitaet Bochum, Bad Oeynhausen, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Schindhelm Florian</last_name>
    <role>Principal Investigator</role>
    <affiliation>Herz- und Diabeteszentrum NRW, Ruhr-Universitaet Bochum, Bad Oeynhausen, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heart - and Diabetes CenteHerz- und Diabeteszentrum NRW, Ruhr-Universitaet Bochum, Bad Oeynhausen</name>
      <address>
        <city>Bad Oeynhausen</city>
        <state>North - Rhine Westfalia</state>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2017</study_first_submitted>
  <study_first_submitted_qc>March 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2017</study_first_posted>
  <last_update_submitted>March 30, 2017</last_update_submitted>
  <last_update_submitted_qc>March 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heart and Diabetes Center North-Rhine Westfalia</investigator_affiliation>
    <investigator_full_name>Thomas Bitter</investigator_full_name>
    <investigator_title>Senior Physician</investigator_title>
  </responsible_party>
  <keyword>Sleep-Disordered Breathing</keyword>
  <keyword>Heart Failure</keyword>
  <keyword>Leg Fluid Shift</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Sleep Apnea, Central</mesh_term>
    <mesh_term>Cheyne-Stokes Respiration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

